Navigation Links
Upcoming Symposium to Bridge the Gap between Osteoporosis Research and its Applications to Clinical Practice with Focus on Secondary Osteoporosis, Osteoporosis in Men, and Lessons from Space Travel for Improving Bone Health
Date:4/1/2009

Advances In Osteoporosis Prevention, Diagnosis And Treatment Presented At 8th International Symposium Of National Osteoporosis Foundation

WASHINGTON, April 1 /PRNewswire-USNewswire/ -- A faculty of internationally-renowned osteoporosis experts are gathering today to share the latest clinically-relevant information on osteoporosis prevention, diagnosis and treatment at the National Osteoporosis Foundation's (NOF) 8th International Symposium on Osteoporosis (ISO8): "Translating Research Into Clinical Practice," April 1-5, 2009 at the Marriott Wardman Park Hotel in Washington, D.C. Held once every two years, ISO8 aims to bridge the gap between osteoporosis research and its application in clinical practice.

Conference presenters will focus on the role of common, chronic diseases in the incidence of osteoporosis, including diabetes, depression, stroke and Parkinson's disease, as well as NOF's recently released Clinician's Guide to Prevention and Treatment and the World Health Organization's FRAX(R) tool, which aid clinicians in evaluating a patient's risk for fracture. Additionally, presenters will address emerging therapies and diagnostic techniques; skeletal development across the lifespan; and clinical guidelines for diagnosing and treating men with osteoporosis.

Peter Cavanagh, Ph.D., University of Washington, professor of orthopaedics and sports medicine, will present a keynote address from his study in which 22 volunteers remain in bed simulating the weightlessness of spaceflight. The study findings offer for the first time a way to prevent bone loss in a specific region of the hip.

"Osteoporosis and low bone mass are conditions that increase the risk of serious and disabling fractures, affecting 44 million Americans or 55 percent of the population age 50 and older," said Robert Recker, MD, president of NOF. "Despite all we know about osteoporosis, it remains a disease that is significantly under-diagnosed and under-treated. The information shared at ISO8 will provide clinicians with the most current information and data to prevent osteoporosis, identify people at risk more accurately, and properly diagnose and treat those with the disease."

Another major topic of discussion will be the National Action Plan for Bone Health: Recommendations from the Summit for a National Action Plan for Bone Health. "Osteoporosis often goes undetected in patients until a fracture occurs, leading to severe physical, social, functional and psychological consequences," said Leo Schargorodski, executive director of NOF. "This report serves as a blueprint for public health action to reduce the burden of osteoporosis in the U.S."

According to NOF prevalence estimates and reinforced in Bone Health and Osteoporosis: A Report of the Surgeon General, osteoporosis is a major public health threat for the nation. In the U.S. today, one in two women and one in four men will break a bone due to osteoporosis in their remaining lifetime.

Celebrating its 25th anniversary, the National Osteoporosis Foundation is the nation's leading voluntary health organization solely dedicated to osteoporosis and bone health. Our mission is to prevent osteoporosis and related fractures, to promote lifelong bone health, to help improve the lives of those affected by osteoporosis, and to find a cure through programs of awareness, advocacy, patient and health professional education, and research. For more information, contact NOF online at www.nof.org or by telephone at (800) 223-9994.


'/>"/>
SOURCE National Osteoporosis Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pharmasset to Present at Two Upcoming Investor Conferences
2. Toes With Nail Fungus Will Be Exposed During Upcoming Summer Sandal Months: Prepare Now
3. Birdstep Technology Announces The Dual Upcoming Release Of Its Raima Database Manager Products
4. Upcoming World Kidney Day Underscores Role of Low-Cost Lab Tests in Combating High-Cost Kidney Disease
5. Beckman Coulter to Present at Upcoming Healthcare Conferences
6. RIEMSER Announces Upcoming Atlanta Bone Grafting Workshop
7. Pharmasset to Present at Two Upcoming Investor Conferences
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Gentiva(R) Health Services to Present at Upcoming Investor Conferences
10. WellPoint Announces Appearances at Upcoming Conferences
11. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s ... the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch about the ... , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing women access ...
(Date:3/27/2017)... , ... March 27, 2017 , ... The Case Management ... of Directors on June 30, 2017. CMSA’s membership has elected their upcoming President-Elect, ... our current Military Advisory position, a new VA Advisory position has also been added ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider of ... row; they are the recipient of the prestigious “Best Overall Design Strategy in ... at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers and ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society , ... more than 95%. Once the cancer spreads to other organs, bones, or lymph nodes, ... how to avoid this latter group, tune in to Lifestyle Magazine on ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
Breaking Medicine Technology: